Citius pharmaceuticals, inc. (CTXR)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10
Cash Flows From Operating Activities:
Net Loss

-4,424

-4,322

-3,649

-4,405

-3,631

-3,874

-2,846

-2,021

-4,421

-3,246

-3,043

-2,422

-2,743

-2,175

-2,589

-3,615

-869

-1,220

-908

-824

-345

-823

-612

-34

-90

-534

-15

-4

-10

-1

-5

-6

-7

-2

-2

-7

-7

-9

Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

10

10

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation - general and administrative

158

220

137

204

203

171

150

124

214

290

178

266

300

241

216

278

115

121

105

163

108

108

470

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for services and release agreements

306

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of operating lease right-of-use asset

47

34

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on revaluation of derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,485

-197

23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on revaluation of derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

263

60

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) loss on revaluation of derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

-133

-179

622

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for release agreement

-

-

-

-

-

-

-

-

-

257

-

123

298

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Other receivables

-

-

0

0

0

-818

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-2

7

3

-2

0

-11

-15

8

-46

-109

-137

-118

-161

-154

-273

373

-60

0

-

-

-

-

-

-

-

-9

-

-

0

0

-

-

-

-

-

-

-

-

Accounts payable

-22

-1,166

282

504

-157

509

661

-488

839

-41

-1,375

114

877

76

599

-57

-336

-100

224

-9

144

92

-30

-43

8

-17

11

0

-0

0

-

-

-

0

0

0

-5

5

Accrued expenses

-59

-37

88

-17

-24

18

66

-27

-23

55

-94

-1,201

9

888

373

-418

-129

526

-18

18

7

-59

60

-3

0

3

-1

-0

0

-0

0

0

0

0

-

-

-

-

Accrued compensation

-444

75

195

185

-361

182

263

140

-408

140

-155

136

71

107

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

160

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest - related parties

-3

-3

-4

-4

-4

-4

-3

-3

-4

-3

-21

-33

-19

-13

-4

-2

0

0

-15

0

0

7

19

30

29

24

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability

-34

-15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Due to related party

-

-

-

-

-

-

0

0

-17

-10

-

0

0

0

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

1

0

0

0

0

0

0

-

-

0

0

Net Cash Used In Operating Activities

-4,467

-5,114

-2,907

-3,522

-3,849

-2,158

-2,504

-2,246

-4,126

-2,441

-3,429

-2,402

-824

-1,314

-1,766

-2,561

-874

-697

-705

-628

-316

-734

-102

-48

-32

-521

-7

-3

-9

-0

-5

-5

-6

-2

-4

-5

-7

-3

Net Cash Provided By (Used In) Investing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

Proceeds from (repayments of) bank overdrafts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

Proceeds from notes payable – related parties

-

-

-

-

-

-

-

-

-

-

300

2,560

530

820

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8

3

6

2

13

5

6

1

Net proceeds from common stock warrant exercises

6,027

0

0

0

7

16

0

0

0

1,125

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from notes payable - related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

600

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of related party debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

-

-

-

Repayments of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

-

-

-

Net proceeds from private placement

-

-

-

-

-

-

-

-

-

-

0

0

308

247

0

1,029

4,096

302

430

819

260

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from public offering

-

-

-

-

-

-

-

0

1,763

5,482

6,116

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

25

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from non-related party debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

13

-0

0

14

2

0

0

-

-

-

-

Net Cash Provided By Financing Activities

6,027

0

6,290

4,834

7

16

8,926

0

1,763

6,607

6,436

2,540

838

1,067

435

429

4,096

302

430

819

260

0

1,630

50

0

575

7

3

9

0

5

6

6

2

5

5

6

1

Net Change in Cash and Cash Equivalents

1,559

-5,114

3,383

1,311

-3,842

-2,142

6,422

-2,246

-2,362

4,166

3,005

137

14

-247

-1,331

-2,132

3,477

-394

-274

190

-56

-734

1,528

1

-32

53

-0

-0

-0

-0

-0

0

-0

0

0

0

-0

-1

Supplemental Disclosures Of Cash Flow Information and Non-cash Activities:
Operating lease right-of-use asset and liability recorded upon adoption of ASC 842

0

1,137

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Income taxes paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Fair value of private placement warrants recorded as derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

157

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of derivative warrant liability to additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-203

619

664

149

444

535

114

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Par value of common stock issued upon cashless exercise of warrants

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of private placement warrants recorded as derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

117

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of promissory notes and accrued interest into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

633

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of convertible promissory notes and accrued interest into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,836

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-